Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ON-DEMAND WEBINARS
During this panel discussion, key opinion leaders from biopharma and academia explore ways to bridge the knowledge gap that exists between these groups and foster research collaborations to help advance the use of digital endpoints in clinical development.
During this educational webinar hosted by Xtalks, data experts from ActiGraph and Koneksa Health present a roadmap to help clinical trial sponsors and their partners design and implement a “future-proof” raw data strategy to maximize the long-term value of digital biomarker data.
Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.
Discover how digital consent is working to enhance diversity, empower participants with education, drive quality data, and streamline operations.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-870849774 EDC medrio]( "What Is Electronic Data Capture And How Does It Simplify Data Management?")
What Is Electronic Data Capture And How Does It Simplify Data Management?As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.
-
![Clinical Trial concept]( "Build Versus Buy: What's The Best Tech Tool For Study Activation?")
Build Versus Buy: What's The Best Tech Tool For Study Activation?In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.
-
![GettyImages-1219551222-Patient-Person-Recruitment-Select]( "Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them")
Dysfunctions Of Clinical Trial Vendor Selection And Overcoming ThemVendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.
-
![GettyImages-1394355488 data]( "The Significance Of Quality Data In Meeting FDA Regulatory Scrutiny")
The Significance Of Quality Data In Meeting FDA Regulatory ScrutinyData Science expert Rod McGlashing explains how scrutiny from the FDA spurs regulatory compliance, resulting in better data quality and the creation of optimal applications for intellectual property.
-
![GettyImages-1148338251 regulations]( "Taking Advantage Of EMA CTR For eCOA Studies In EU")
Taking Advantage Of EMA CTR For eCOA Studies In EUDiscover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).
-
![GettyImages-1443965506 doctor clinical trial data monitoring]( "How Optina Diagnostics Used EDC In Earlier Disease Detection")
How Optina Diagnostics Used EDC In Earlier Disease DetectionUnderstand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
-
![Global-connection-GettyImages-1335295270]( "3 Key Functions Your eTMF Needs To Meet New EMA Regulations")
3 Key Functions Your eTMF Needs To Meet New EMA RegulationsThe European Union Clinical Trial Regulation No. 536/2014 recently introduced the most significant changes to the processes for clinical trial applications in at least the past 15 years. Learn how this impacts the Trial Master File and consider three key functions that an electronic TMF must have to achieve compliance and maintain organizational success.
-
![doctor meeting clinical iStock-846002754]( "Bridging Clinical Efficacy And Real-World Effectiveness In Digital Therapeutics Trials")
Bridging Clinical Efficacy And Real-World Effectiveness In Digital Therapeutics TrialsNo matter how conclusive clinical evidence is for medical treatments, developers may struggle to see precisely how their treatment performs in the real world—outside the controlled environment of the clinic or office.
-
![GettyImages-1314299046 econsent]( "Comparative Effectiveness Of eConsent: Systematic Review")
Comparative Effectiveness Of eConsent: Systematic ReviewThis blog post examines eConsent vs. ICF on comprehension, acceptability, enrollment, retention, consent time, and site workload.
-
![laboratory scientist laptop GettyImages-1302454417]( "Future Predictions For Clinical Technologies")
Future Predictions For Clinical TechnologiesIn 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
